Welcome to the upgraded BRAC University Institutional Repository. We are currently organizing collections after a recent system upgrade. Homepage category counters may temporarily show lower numbers while syncing, but over 27,000 repository items remain safe and accessible. Please use the search bar to find theses, scholarly outputs, and institutional documents.

Drug repurposing in NCDs: benefits and challenges

bracu.degree.levelUndergraduate
bracu.type.groupStudent Works
datacite.rightsOpen Access
dc.contributor.advisorKabir, Eva Rahman
dc.contributor.authorNasir, Naushin Sadia
dc.contributor.departmentDepartment of Pharmacy
dc.date.accessioned2021-12-26T09:03:47Z
dc.date.available2021-12-26T09:03:47Z
dc.date.copyright2021
dc.date.issued2021-04
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 34-49).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.en_US
dc.description.abstractThis review focuses on repurposing of drugs for the treatment of noncommunicable diseases. Drug repurposing is the development of new indications for existing drugs. Noncommunicable diseases are causing large number of deaths every year. Therefore, drug repurposing is an effective strategy for the treatment of noncommunicable diseases. This review discusses the methods, benefits and challenges of drug repurposing as well as all the approved repurposed drugs for NCDs and the repurposed drugs that are awaiting approval by the FDA. Considering the challenges faced due to repurposing of drugs, some recommendations are put forward to improve the future of drug repurposing.en_US
dc.description.degreeBachelor of Pharmacy
dc.description.statementofresponsibilityNaushin Sadia Nasir
dc.format.extent49 pages
dc.identifier.otherID 17146047
dc.identifier.urihttp://hdl.handle.net/10361/15764
dc.language.isoenen_US
dc.publisherBRAC Universityen_US
dc.rightsBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.
dc.subjectDrug repurposingen_US
dc.subjectNoncommunicable diseaseen_US
dc.subjectMarket and data exclusivityen_US
dc.subjectBenefits and challengesen_US
dc.subject.lcshCommunicable diseases
dc.subject.lcshChronic diseases--Treatment
dc.subject.lcshDrug development
dc.titleDrug repurposing in NCDs: benefits and challengesen_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
17146047_PHR.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: